| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Johnson David Michael | Director | C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON | /s/ Conor Kilroy, as Attorney-in-Fact | 2025-06-18 | 0001808098 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AURA | Common Stock | Award | $0 | +13K | +7.82% | $0.00 | 179K | Jun 17, 2025 | Direct | F1 |
| holding | AURA | Common Stock | 75K | Jun 17, 2025 | By NEJ09 IRREVOCABLE TRUST | F2 | |||||
| holding | AURA | Common Stock | 75K | Jun 17, 2025 | By NEJ12 IRREVOCABLE TRUST | F3 | |||||
| holding | AURA | Common Stock | 140K | Jun 17, 2025 | By Velocity Capital Management | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AURA | Stock Option (Right to Buy) | Award | $0 | +17K | $0.00 | 17K | Jun 17, 2025 | Common Stock | 17K | $6.18 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. |
| F2 | The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee. |
| F3 | The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee. |
| F4 | Velosity Capital Management LLC is an entity that the Reporting Person is the sole member of. |
| F5 | This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. |